Estimates Revisions Alterity Therapeutics Limited Nasdaq
Stocks
ATHE
US02155X2053
Biotechnology & Medical Research
|
Delayed
Nasdaq
09:27:42 24/08/2026 pm IST
|
5-day change | 1st Jan Change | ||
| 4.582 USD | -1.88% |
|
+0.27% | +48.78% |
Turnover - Evolution of Analysts' Estimates
Earnings Per Share (EPS) - Evolution of Analysts' Estimates
EBIT - Evolution of Analysts' Estimates
Cash or Net Debt - Evolution of Analysts' Estimates
| 1m. Revenue rev. | 1y. Revenue rev. | 1y. EPS revision | ||
|---|---|---|---|---|
 | ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| - | |||
| ||||
| ||||
| Average | ||||
| Weighted average by Cap. |
Turnover
Earnings Per Share (EPS)
EBIT
Cash or Net Debt
- Stock Market
- Stocks
- ATH Stock
- ATHE Stock
- Consensus Alterity Therapeutics Limited
- Estimates Revisions
Select your edition
All financial news and data tailored to specific country editions
